Bio-Techne (TECH) Tops Q1 EPS by 2c, Beats on Revenues

Bio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.90, $0.02 better than the analyst estimate of $0.88. Revenue for the quarter came in at $144.6 million versus the consensus estimate of $142.92 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M